Michael Newberg | CNBC
Andrew Left, executive editor, Citron Research
Citron Research’s Andrew Left is betting against Twitter less than two months after the short-seller made an unusual and public bullish bet on the social media company.
div > div.group > p:first-child”>
Left, who has gained notoriety for successful bets against stocks such as Valeant Pharmaceuticals, explained that his rapid change of view on Twitter came as a result of the growing scrutiny surrounding social media and how companies handle users’ personal information.
“Everything’s changed; everyone is talking about data privacy,” Left told CNBC. “They’re a lot more vulnerable than Facebook. … If you’re involved in the market you’ve got to stay aware of the news.”